Clozapine Nursing Care Plan
Prepared by: [YOUR NAME]
Email: [YOUR EMAIL]
Date: January 1, 2050
Patient Details
Field | Details |
|---|
Patient Name | John Casper |
Age | 35 |
Gender | Male |
Diagnosis | Treatment-Resistant Schizophrenia |
Medication | Clozapine 300 mg/day |
Plan Start Date | January 1, 2050 |
Plan Review Date | April 1, 2050 |
Nursing Diagnosis and Goals
Nursing Diagnosis | Goals |
|---|
Risk of infection related to agranulocytosis secondary to clozapine | Ensure patient maintains an absolute neutrophil count (ANC) above 1,500/mm³. |
Non-adherence to medication regimen | Patient will demonstrate consistent adherence to medication by March 1, 2050. |
Risk of weight gain and metabolic syndrome due to medication | Limit weight gain to no more than 5% of baseline weight within three months. |
Interventions and Rationales
Intervention | Rationale | Expected Outcome |
|---|
Educate the patient on the importance of routine blood tests (weekly for the first six months, then biweekly). | Early detection of agranulocytosis is critical to prevent complications. | Patient completes 100% of scheduled blood tests by the next review date. |
Encourage a low-calorie, nutrient-dense diet and regular physical activity. | Mitigates weight gain and reduces the risk of metabolic syndrome. | Patient engages in at least 30 minutes of exercise, 3 times a week. |
Monitor for side effects such as sedation, hypotension, or signs of infection (e.g., fever, sore throat). | Early identification of adverse effects ensures timely intervention. | Patient remains free from infections and severe side effects by review date. |
Monitoring and Documentation
Parameter | Frequency | Notes |
|---|
ANC (Absolute Neutrophil Count) | Weekly for 6 months, biweekly thereafter | Ensure results are communicated promptly to the healthcare provider. |
Weight and BMI | Monthly | Monitor trends and adjust dietary/exercise interventions as needed. |
Blood Pressure | Every visit (biweekly) | Watch for orthostatic hypotension and adjust medication if required. |
Patient and Caregiver Education Plan
Topic | Details |
|---|
Purpose of clozapine | Explain how clozapine helps manage treatment-resistant schizophrenia. |
Signs of potential side effects to report | Educate on symptoms like fever, extreme fatigue, or sore throat. |
Importance of adherence and follow-ups | Stress the importance of taking medication and attending scheduled check-ups. |
Evaluation
Criteria | Date | Evaluation Outcome |
|---|
ANC within normal limits | February 1, 2050 | Achieved. No signs of agranulocytosis. |
Patient adhering to medication regimen | March 1, 2050 | On track. Patient reports no missed doses. |
Weight gain controlled | April 1, 2050 | Partially achieved. Weight gain <5% from baseline. |
Plan Templates @ Template.net
